Santander UK Group Holdings plc set terms for $1,500,000,000 5.314% fixed-rate/floating-rate notes due 2030 and $1,000,000,000 6.046% notes due 2037. Investors receive defined note maturities, par Redemption dates and floating-rate provisions under the supplemental indenture, including terms for benchmark replacement if the reference rate changes.
Key Highlights
- The 2037 notes have a par redemption date of September 15, 2036.
- The notes have par redemption dates of September 15, 2029, and September 15, 2036.
- Citibank, N.A. serves as Trustee under the supplemental indenture.
Note Terms and Trustee Arrangements
The 2030 notes mature on September 15, 2030, with par redemption available on September 15, 2029. The 2037 notes mature on September 15, 2037, and have a par redemption date of September 15, 2036. Citibank, N.A. is trustee, following Wells Fargo Bank, National Association’s resignation under an agreement dated March 4, 2021.
Floating-Rate and Benchmark Provisions
The notes contain provisions for replacing the applicable benchmark if a transition event occurs. Each alternative may include a benchmark replacement adjustment, which can be positive, negative or zero. Business days exclude Saturdays, Sundays and certain legal holidays affecting banking institutions in New York or London.
FAQs
Q: What notes is Santander UK Group Holdings issuing?
A: The article refers to the 2030 notes and the 2037 notes. It does not state their initial interest rates.
Q: When do Santander UK’s new notes mature?
A: Santander UK’s 2030 notes mature on September 15, 2030. The 2037 notes mature on September 15, 2037, and have a par redemption date of September 15, 2036.
Q: Who is trustee for the Santander UK notes?
A: Citibank, N.A. serves as trustee under the supplemental indenture. Wells Fargo Bank, National Association previously served as trustee before its resignation.
Download Free Report – Explore 3 Stock Ideas & Industry Insights
Unlock 3 stock ideas and key industry insights in our free report. This information is general in nature and does not consider your personal objectives, financial situation, or needs. It is not financial advice.
All investments involve risk—consider independent advice before making any investment decisions.
View 3 Research Reports
Disclaimer:
Kalkine Equities LLC, with Delaware File Number 4697384, Foreign Qualification Registration in California File Number 202109211078, and Texas File Number 805521396, is authorized to provide general advice only. The information on https://kalkine.com/ does not take into account any of your investment objectives, financial situation or needs. You should consider the appropriateness of advice taking into account your own objectives, financial situation and needs and seek independent financial advice before making any financial decisions. The link to our Terms and Conditions and Privacy Policy has been provided for your reference. On the date of publishing the reports (mentioned on the website), employees and/or associates of Kalkine do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations later.